NTRA

#443
Natera, Inc. Common Stock
214.64 USD
+6.31%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
214.64
214.64
年范围
131.81
256.27
日变化
+6.31%
每月变动
+12.12%
6个月变化
+23.90%
年变化
+44.16%
前一天收盘价
201.90
开盘价
214.64
买价
卖价
最低价
214.64
High
214.64
交易量
150
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 30.42 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-150.72
市销率
13.58

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

新闻